Lab Med Online.  2020 Oct;10(4):340-342. 10.47429/lmo.2020.10.4.340.

The First Case of Extensively Drug-resistant Salmonella Typhi in South Korea

• Lee NY
• Ham JY
• Song KE
• Kim S

• KMID: 2512276
• DOI: http://doi.org/10.47429/lmo.2020.10.4.340

Reference

1. Buchan BW, Faron ML, Humphries RM, Dekker J, Ledeboer NA. Carroll KC. 2019. Escherichia, Shigella, and Salmonella. Manual of clinical microbiology. 12th ed. ASM Press;Washington DC: p. 688–723.

2. Freedman J, Lighton L, Jones J. 2014; Defining travel-associated cases of enteric fever. J Infect Public Health. 7:377–85. DOI: 10.1016/j.jiph.2013.07.011. PMID: 24602772. PMCID: PMC6927305.

3. Wong MH, Yan M, Chan EW, Biao K, Chen S. 2014; Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin. Antimicrob Agents Chemother. 58:3752–6. DOI: 10.1128/AAC.02770-13. PMID: 24752251. PMCID: PMC4068579.

4. Britto CD, Wong VK, Dougan G, Pollard AJ. 2018; A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. PLoS Negl Trop Dis. 12:e0006779. DOI: 10.1371/journal.pntd.0006779. PMID: 30307935. PMCID: PMC6198998.

5. Clinical and Laboratory Standards Institute. 2019. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. 29th ed. Clinical and Laboratory Standards Institute;Wayne, PA:

6. Chatham-Stephens K, Medalla F, Hughes M, Appiah GD, Aubert RD, Caidi H, et al. 2019; Emergence of extensively drug-resistant Salmonella Typhi infections among travelers to or from Pakistan - United States, 2016-2018. MMWR Morb Mortal Wkly Rep. 68:11–3. DOI: 10.15585/mmwr.mm6801a3. PMID: 30629573. PMCID: PMC6342547.

7. Rowe B, Ward LR, Threlfall EJ. 1997; Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis. 24:S106–9. DOI: 10.1093/clinids/24.Supplement_1.S106. PMID: 8994789. PMCID: PMC6953460.

8. Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, et al. 2018; Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. mBio. 9:e00105–18. DOI: 10.1128/mBio.00105-18. PMID: 29463654. PMCID: PMC5821095.

9. Wong W, Rawahi HA, Patel S, Yau Y, Eshaghi A, Zittermann S, et al. 2019; The first Canadian pediatric case of extensively drug-resistant Salmonella Typhi originating from an outbreak in Pakistan and its implication for empiric antimicrobial choices. IDCases. 15:e00492. DOI: 10.1016/j.idcr.2019.e00492. PMID: 30815359. PMCID: PMC6378779.

10. Yousafzai MT, Qamar FN, Shakoor S, Saleem K, Lohana H, Karim S, et al. 2019; Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine. Clin Infect Dis. 68:S16–21. DOI: 10.1093/cid/ciy877. PMID: 30767003. PMCID: PMC6376099.